Biosig Technologies (BSGM) Competitors $6.34 +1.90 (+42.58%) Closing price 09/11/2025Extended Trading$6.34 0.00 (0.00%) As of 09/11/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BSGM vs. AXGN, CLPT, SIBN, BVS, AVNS, ZIMV, BFLY, KIDS, TMCI, and SMLRShould you be buying Biosig Technologies stock or one of its competitors? The main competitors of Biosig Technologies include AxoGen (AXGN), ClearPoint Neuro (CLPT), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), Butterfly Network (BFLY), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), and Semler Scientific (SMLR). These companies are all part of the "medical equipment" industry. Biosig Technologies vs. Its Competitors AxoGen ClearPoint Neuro SiBone Bioventus AVANOS MEDICAL ZimVie Butterfly Network OrthoPediatrics Treace Medical Concepts Semler Scientific Biosig Technologies (NASDAQ:BSGM) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership. Do insiders and institutionals have more ownership in BSGM or AXGN? 7.2% of Biosig Technologies shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 24.8% of Biosig Technologies shares are owned by insiders. Comparatively, 2.8% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer BSGM or AXGN? Biosig Technologies currently has a consensus target price of $10.00, indicating a potential upside of 57.60%. AxoGen has a consensus target price of $25.75, indicating a potential upside of 50.06%. Given Biosig Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Biosig Technologies is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biosig Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00AxoGen 1 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.60 Which has more volatility and risk, BSGM or AXGN? Biosig Technologies has a beta of 1.82, indicating that its share price is 82% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Is BSGM or AXGN more profitable? Biosig Technologies has a net margin of 0.00% compared to AxoGen's net margin of -2.29%. AxoGen's return on equity of -4.43% beat Biosig Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Biosig TechnologiesN/A -5,336.99% -90.03% AxoGen -2.29%-4.43%-2.34% Which has stronger valuation and earnings, BSGM or AXGN? AxoGen has higher revenue and earnings than Biosig Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiosig Technologies$13K15,334.89-$10.33MN/AN/AAxoGen$187.34M4.21-$9.96M-$0.10-171.60 Does the media refer more to BSGM or AXGN? In the previous week, AxoGen had 27 more articles in the media than Biosig Technologies. MarketBeat recorded 27 mentions for AxoGen and 0 mentions for Biosig Technologies. AxoGen's average media sentiment score of 0.48 beat Biosig Technologies' score of 0.00 indicating that AxoGen is being referred to more favorably in the news media. Company Overall Sentiment Biosig Technologies Neutral AxoGen Neutral SummaryAxoGen beats Biosig Technologies on 8 of the 14 factors compared between the two stocks. Get Biosig Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BSGM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BSGM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSGM vs. The Competition Export to ExcelMetricBiosig TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$199.35M$6.97B$6.10B$10.65BDividend YieldN/A1.15%5.70%4.74%P/E RatioN/A27.6685.5527.59Price / Sales15,334.89198.81621.78138.47Price / CashN/A22.0037.7861.77Price / Book-70.505.4513.136.76Net Income-$10.33M$178.04M$3.30B$275.88M7 Day PerformanceN/A5.08%5.29%3.72%1 Month Performance63.53%12.65%9.94%10.22%1 Year Performance2,404.93%35.38%87.78%35.86% Biosig Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSGMBiosig Technologies1.7856 of 5 stars$6.35+42.6%$10.00+57.6%+2,040.0%$199.35M$13K0.0050Gap DownHigh Trading VolumeAXGNAxoGen3.1316 of 5 stars$17.26+0.6%$26.00+50.6%+23.4%$789.58M$187.34M-172.58450Analyst ForecastInsider TradeCLPTClearPoint Neuro0.6859 of 5 stars$21.57+0.1%$19.67-8.8%+144.4%$612.61M$31.39M-26.63110Analyst ForecastGap UpSIBNSiBone3.9834 of 5 stars$14.17+0.9%$23.67+67.0%+15.8%$606.13M$167.18M-25.30350Positive NewsAnalyst ForecastBVSBioventusN/A$6.62-0.6%N/AN/A$550.64M$573.28M13.321,200Analyst ForecastAVNSAVANOS MEDICAL2.1228 of 5 stars$11.55-1.9%N/A-49.9%$546.16M$687.80M-1.152,227Positive NewsZIMVZimVie1.3999 of 5 stars$18.90-0.1%$17.75-6.1%+22.6%$533.47M$443.40M-27.001,770Analyst ForecastBFLYButterfly Network2.2877 of 5 stars$1.96-2.7%$3.00+53.5%+34.3%$506M$82.06M-6.98460News CoverageAnalyst ForecastOptions VolumeKIDSOrthoPediatrics4.6366 of 5 stars$18.31+0.2%$34.14+86.5%-26.8%$458.35M$204.73M-10.23200Positive NewsAnalyst ForecastTMCITreace Medical Concepts2.5785 of 5 stars$6.72+0.9%$9.83+46.3%+14.5%$420.73M$209.36M-8.51250News CoverageAnalyst ForecastSMLRSemler Scientific3.3124 of 5 stars$29.24+3.3%$74.25+153.9%+11.8%$419.12M$56.29M12.03120Analyst ForecastGap Up Related Companies and Tools Related Companies AxoGen Competitors ClearPoint Neuro Competitors SiBone Competitors Bioventus Competitors AVANOS MEDICAL Competitors ZimVie Competitors Butterfly Network Competitors OrthoPediatrics Competitors Treace Medical Concepts Competitors Semler Scientific Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BSGM) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersTesla’s $30 trillion pivotCircle Nov 6 – huge Tesla news? Tesla could be about to change forever. On November 6, insiders are warning...Altimetry | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biosig Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biosig Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
